Microbiological analyses

Respiratory Syncytial Virus (RSV)

The Virus

The respiratory syncytial virus (RSV) has a genome and it’s a negative single-stranded RNA virus. It belongs to the Mononegavirales order, to the Paramyxoviridae family, to the Pneumovirinae subfamily and to the Pneumovirus genus. There are different variants of the virus which can infect mammals such as bovines, ovine, mice, etc. On the contrary, the human variant hRSV is the most important etiologic agent of bronchiolitis and childish pneumonia.

 

Clinical manifestations

The incubation period is of 4 days. The infection goes on through saliva’s drops expectorated by the infected child and which are breathed or carried at conjunctivitis level of others children. The infected child diffuses the virus in the environment for about 5-12 days. The infection generally appears with a nasal secretion and throat ache, then cough and fever. In serious cases the infection becomes graver. There are whistles, cough becomes more serious and there are breathing difficulties and cyanosis. The prognosis of this illness is more serious in infants, in preemies and in children who have a case with nervous system, cardiovascular apparatus, pulmonary or immunologic illness.

 

Epidemiology

The hRSV diffuses in annual epidemics, which normally appears every winter and that normally go on for 4-5 months. The endemic pick normally occurs in January, February and March. The acquired immunity after the hRSV infection is incomplete and it goes on for a short period of time. That means that reinfections can easily appear. Bronchiolitis and pneumonia from hRSV are frequent in nursing up to one year old. Indeed, even the possible presence at high levels of maternal anti-hRSV and via milk transmitted antibodies couldn’t neutralize the virus.

 

Treatment

the therapy of not complicated form is symptomatic. By using oxygen to simplify breathing the only medicament, which demonstrated an activity against the VRS is the ribavirin in aerosol.

 

Test

The BinaxNOW RSV test is destined to the rapid and qualitative survey of the fusion protein of the respiratory syncytial virus (hRSV) directly in samples, such as nose washing and nasal-pharynx swab in children younger than 5.

 

Sample taking

The analysis is carried out on nasal-pharynx swabs (ex: polyester, rayon, cotton and foam) and o nasal washing samples. It’s recommendable not to use nasal-pharynx swabs in calcium alginic acids.

< Back

Documents

Certification

1. Swissmedic

 

2. ISO/IEC 17025

General requirements for the competence of testing and calibration laboratories

Laboratorio di Diagnostica Molecolare SA
LDM IT
Via G. Petrini 2
CH-6900 Lugano
+41 (0)91 9603700
info@ldm.ch

Privacy policy

Impressum
General Terms & Conditions

Online payment methods

PostFinance e-financePostFinance cardVisaMatercardTwint